Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05821504 · ClinicalTrials.gov registry record · NA

High-Intensity Interval Training and Performance

A NA study, sponsored by Kennesaw State University.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT05821504: Completed NA study, sponsored by Kennesaw State University.

NCT05821504 is a NA study that has completed, run by Kennesaw State University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05821504, a NA study, has completed, sponsored by Kennesaw State University.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

The goal of this clinical trial was to compare to different types of high-intensity interval training in young, healthy females. The main questions were: Will changes in body composition differ between the two interventions? Will changes in endurance and muscle performance differ between the two interventions? Participants were randomized to 8 weeks of high-intensity interval training involving body weight, plyometric exercises or cycling only. Researchers compared changes in endurance performance, body composition, and muscle performance to determine if there were differences between groups.

Primary Outcome

echo-intensity value derived from ultrasound that indicates the amount of fat infiltration in muscle

Interventions

  • BEHAVIORAL High-Intensity Interval Training

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2018-08-01
Est. Completion 2018-11-21
Phase NA
Kennesaw State University

8 total trials

What the finished NCT05821504 record still lists

NCT05821504 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which High-Intensity Interval Training is the first listed.

NCT05821504 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05821504 about?

NCT05821504 is a clinical study titled "High-Intensity Interval Training and Performance". The goal of this clinical trial was to compare to different types of high-intensity interval training in young, healthy females. The main questions were: Will changes in body composition differ between the two interventions? Will changes in endurance and muscle performance differ between the two int...

What is the current status of trial NCT05821504?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2018-08-01. Estimated completion is 2018-11-21.

What interventions are being tested in trial NCT05821504?

The interventions under investigation include: High-Intensity Interval Training (BEHAVIORAL).

Who is sponsoring clinical trial NCT05821504?

This trial is sponsored by Kennesaw State University, which has 8 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05821504's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05821504, the US trial registry maintained by the National Library of Medicine. NCT05821504 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.